Home Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm
Article
Licensed
Unlicensed Requires Authentication

Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm

  • W. Heyl , B. Heintz , F. Reister , S. Harwig , K. Witte , B. Lemmer and W. Rath
Published/Copyright: June 1, 2005
Journal of Perinatal Medicine
From the journal Volume 33 Issue 2

Abstract

Objective: Soluble vascular cell adhesion molecule-1 (VCAM-1) is known to be elevated in serum of patients with preeclampsia, but there are no data available on the significance of urinary VCAM-1 excretion in preeclampsia. The aim of our study was to uncover possible circadian rhythms of VCAM-1 plasma levels and urinary VCAM-1 excretion in uncomplicated and hypertensive pregnancies and to ascertain their relation to blood pressure.

Study design: A total of 10 normotensive and 10 preeclamptic pregnant women were included in this study. Venous blood was collected hourly, and urine samples were taken every 2 h over a period of 24 h. VCAM-1 levels were determined by ELISA. We compared these results with the circadian blood pressure rhythm.

Results: The median VCAM-1 plasma levels were significantly (P<0.01) increased in preeclamptic patients (851.5 ng/mL) in comparison to normotensive pregnant women (659.3 ng/mL) without any circadian rhythm being apparent; however, the urinary excretion of VCAM-1 showed a typical circadian rhythm, with a higher excretion rate during daytime.

Conclusion: For the first time we have demonstrated that urinary VCAM-1 excretion in pregnancy shows a circadian rhythm without correlation to plasma levels or the circadian blood pressure rhythm. In contrast, VCAM-1 serum levels did not show a diurnal rhythm. We assume that VCAM-1 serum levels do not correlate with systemic blood pressure or urinary excretion.

:

Corresponding author: Wolfgang Heyl, MD, Department of Obstetrics and Gynecology, Klinikum Ludwigsburg, Posilipostr. 4, 71640 Ludwigsburg/Germany. Tel.: +49-7141-99-6431; Fax: +49 7141-99-6969;

References

1 Bechtel U, R Scheuer, R Landgraf, A Konig, HE Feucht: Assessment of soluble adhesion molecules (sICAM-1, VCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients. Transplantation58 (1994) 905Search in Google Scholar

2 Coata G, L Pennacchi, V Bini, L Liotta, GC Di Renzo: Soluble adhesion molecules: marker of pre-eclampsia and intrauterine growth restriction. J Matern Neonatal Med12 (2002) 28Search in Google Scholar

3 Davey DA, I MacGillivray: The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol158 (1988) 892Search in Google Scholar

4 Gaertner HV. Nephropathy in pregnancy – an endothelial lesion? Zentralbl Gynaekol116 (1994) 123Search in Google Scholar

5 Gordon JL, RM Edwards, SJ Cashman, AJ Rees, AJH Gearing: Circulating endothelial adhesion molecules. In: Catravas JD, Callow AD, Ryan US (eds): Vascular Endothelium: Physiological Basis of Clinical Problems. Plenum Press, New York 199310.1007/978-1-4615-2437-3_11Search in Google Scholar

6 Hanisch CG, KA Pfeiffer, H Schlebusch, J Schmolling: Adhesion molecules, actin and inhibin – candidates for the biochemical prediction of hypertensive diseases in pregnancy? Arch Gynecol Obstet270 (2004) 110Search in Google Scholar

7 Heyl W, B Heintz, F Reister, M Sadighpur, S Harwig, W Rath: Urinary IL-1beta and TNF-alpha excretion in normo- and hypertensive pregnant women. Kidney Blood Press Res20 (1997) 118Search in Google Scholar

8 Heyl W, S Handt, F Reister, J Gehlen, C Mittermayer, W Rath: The role of soluble adhesion molecules for evaluating endothelial activation in preeclampsia. Am J Obstet Gynecol180 (1999) 68Search in Google Scholar

9 Heyl W, S Handt, F Reister, J Gehlen, C Mittermayer, W Rath: Elevated soluble adhesion molecules in women with preeclampsia: do cytokines like tumor necrosis factor-alpha and interleukin-1beta cause endothelial activation? Eur J Obstet Gynecol Reprod Biol86 (1999) 35Search in Google Scholar

10 Klein CL, H Kohler, F Bittinger, M Wagner, I Hermanns, K Grant, JC Lewis, CJ Kirkpatrick: Comparative studies on vascular endothelium in vitro. I. Cytokine effects on the expression of adhesion molecules by human umbilical vein, saphenous vein and femoral artery endothelial cells. Pathobiology62 (1994) 199Search in Google Scholar

11 Krauss T, G Emons, W Kuhn, HG Augustin: Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin Chem48 (2002) 1418Search in Google Scholar

12 Kupferminc MJ, AM Peaceman, TR Wigton, KA Rehnberg, ML Socol: Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol170 (1994) 1752Search in Google Scholar

13 Lyall F, IA Greer, F Boswell, LM Macara, JJ Walker, JC Kingdom: The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol101 (1994) 485Search in Google Scholar

14 Roberts JM, CA Hubel, RN Taylor: Endothelial dysfunction yes, cytotoxicity no! Am J Obstet Gynecol173 (1995) 978Search in Google Scholar

15 Rodgers GM, RN Taylor, JM Roberts: Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol159 (1988) 908Search in Google Scholar

16 Schiff E, SA Friedman, P Baumann, BM Sibai, R Romero. Tumor necrosis factor-alpha in pregnancies associated with preeclampsia or small-for-gestational-age newborns. Am J Obstet Gynecol170 (1994) 1224Search in Google Scholar

17 Visser W, I Beckmann, HA Bremer, HL Lim, HC Wallenburg: Bioactive tumour necrosis factor alpha in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol101 (1994) 1081Search in Google Scholar

18 Visser W, I Beckmann, MA Knook, HC Wallenburg: Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Acta Obstet Gynecol Scand81 (2002) 713Search in Google Scholar

19 Zabel P, K Linneman, M Schlaak: Circadian rhythm of cytokines. Immun Infekt21 (1993) 38Search in Google Scholar

20 Zuther P, K Witte, B Lemmer: ABPM-FIT and CV-SORT: an easy-to-use software package for detailed analysis of data from ambulatory blood pressure monitoring. Blood Press Monit1 (1996) 347Search in Google Scholar

Published Online: 2005-06-01
Published in Print: 2005-03-01

©2005 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Declining fertility in the developed world and high maternal mortality in developing countries – how do we respond?
  2. Maternal obesity and complications during pregnancy
  3. Cesarean section upon request: is it appropriate for everybody?
  4. Reply to: Cesarean section upon request: is it appropriate for everybody?
  5. Characteristics of mothers who delivered the heaviest, average-weight, and lightest triplet sets
  6. Gestational age-specific distribution of twin birth weight discordance
  7. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy
  8. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS®)
  9. Structural-tridimensional study of yolk sac in pregnancies complicated by diabetes
  10. Is cervical dilatation during parturition at term associated with apoptosis?
  11. Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm
  12. The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term
  13. Amniotic fluid lamellar body counts for the determination of fetal lung maturity: an update
  14. Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants
  15. Sudden infant death syndrome “gray zone” disclosed only by a study of the brain stem on serial sections
  16. Incidence and diagnosis of unilateral arterial cerebral infarction in newborn infants
  17. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection
  18. A new syndrome of myopathy with muscle spindle excess*
  19. Causes of left ventricular hypertrabeculation/non-compaction in a neonate and her mother
Downloaded on 2.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2005.027/pdf
Scroll to top button